Research Spotlight: A Better Understanding of Immune Checkpoint Inhibitor-Related Colitis
This study was designed to investigate which cellular, transcriptional and signaling programs are associated with the development of colitis in cancer patients being treated with immune checkpoint inhibitors (ICIs).